Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia, Moderate”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00112073
What this trial is testing

AAB-001 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 234
Testing effectiveness (Phase 2)Study completedNCT02244541
What this trial is testing

Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Anavex Life Sciences Corp. 32
Large-scale testing (Phase 3)Study completedNCT00478205
What this trial is testing

Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Inc. 1,467
Early research (Phase 1)Not Yet RecruitingNCT07554872
What this trial is testing

Study of Neural Stem Cell-Derived Exosomes in Moderate-to-Severe Early-Onset Alzheimer's Disease

Who this might be right for
Alzheimer Disease (AD)
Shanghai Mental Health Center 9
Testing effectiveness (Phase 2)Study completedNCT00752232
What this trial is testing

Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 40
Testing effectiveness (Phase 2)Ended earlyNCT06833281
What this trial is testing

Extension Study of Participants From SPG302-ALZ-101

Who this might be right for
Alzheimer's Disease
Spinogenix 12
Testing effectiveness (Phase 2)Study completedNCT01735630
What this trial is testing

Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 350
Not applicableStudy completedNCT03060200
What this trial is testing

Reducing Depressive Symptomatology With a Smartphone App

Who this might be right for
Moderate Depression
Babes-Bolyai University 158
Testing effectiveness (Phase 2)Ended earlyNCT02249351
What this trial is testing

Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 54
Not applicableStudy completedNCT02711683
What this trial is testing

DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil

Who this might be right for
Alzheimer's Disease
First Affiliated Hospital Xi'an Jiaotong University 92
Large-scale testing (Phase 3)WithdrawnNCT04187547
What this trial is testing

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Who this might be right for
Alzheimer's Disease
Cerecin
Not applicableStudy completedNCT01329523
What this trial is testing

Compare Genetic Variations of IGF-I and IGF-II

Who this might be right for
Dementia
Avera McKennan Hospital & University Health Center 50
Large-scale testing (Phase 3)Ended earlyNCT01066546
What this trial is testing

An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 5
Testing effectiveness (Phase 2)Study completedNCT04079803
What this trial is testing

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 64
Large-scale testing (Phase 3)WithdrawnNCT00743743
What this trial is testing

Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT00810147
What this trial is testing

A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 209
Not applicableStudy completedNCT02007291
What this trial is testing

Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment

Who this might be right for
Late Onset Alzheimer
Federal University of Minas Gerais 71
Testing effectiveness (Phase 2)Study completedNCT00663026
What this trial is testing

Study Evaluating Bapineuzumab In Alzheimer Disease Subjects

Who this might be right for
Alzheimer Disease
Pfizer 79
Large-scale testing (Phase 3)Study completedNCT00428090
What this trial is testing

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 862
Not applicableUnknownNCT03753191
What this trial is testing

The Effects of Transcranial Direct Current Stimulation on Executive Function in People With Mild to Moderate Dementia

Who this might be right for
DementiaExecutive FunctionTranscranial Direct Current Stimulation
The Hong Kong Polytechnic University 80
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation